FB2025_01 , released February 20, 2025
Human Disease Model Report: cancer, multiple, IDH1,2-related
Open Close
General Information
Name
cancer, multiple, IDH1,2-related
FlyBase ID
FBhh0000525
Disease Ontology Term
Parent Disease
OMIM
Overview

Somatic mutations in the human isocitrate dehydrogenase genes IDH1 (cytosolic) and IDH2 (mitochondrial) have been observed in multiple cancers, including cytogenetically normal acute myeloid leukemia (CN-AML). There is one orthologous gene in flies, Dmel\Idh, for which classical amorphic and loss-of-function alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated. IDH2 is also implicated in D-2-hydroxyglutaric aciduria 2 (MIM:613657; FBhh0000103).

Neither human gene, IDH2 nor IDH1, has been introduced into flies.

Variant(s) implicated in human disease tested (as analogous mutation in fly gene): R163Q in the fly Idh gene (corresponds to R140Q in the human IDH2 gene); R195H in the fly Idh gene (corresponds to R132H in the human IDH1 gene).

Amorphic mutations of Dmel\Idh are homozygous lethals. GAL4-UAS expression of mutational lesions analogous to disease-associated mutations in both human genes, IDH1 and IDH2, result in elevation of D-2-hydroxyglutarate levels. Expression of disease-associated mutations in larval blood cells (hemocytes) resulted in higher numbers of circulating blood cells. Other phenotypes observed include neurologic defects, locomotor defective, and melanotic mass phenotypes. Genetic and physical interactions have been described for Dmel\Idh; see below and in the FlyBase gene report for Idh.

[updated Sep. 2017 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: cancer, multiple, IDH1,2-related
OMIM report
Human gene(s) implicated
Symptoms and phenotype
Genetics

Somatic mutations in the human genes IDH2 or IDH1 have been identified in cytogenetically normal acute myeloid leukemia (CN-AML). While large chromosomal abnormalities can be involved in the development of acute myeloid leukemia, about half of cases do not have these abnormalities; these are classified as CN-AML. Nearly 20% of people with CN-AML have a mutation in the IDH2 gene; approximately 16% have a mutation in the IDH1 gene. [Genetics Home Reference, IDH2, IDH1; 2017.04.17]

Cellular phenotype and pathology
Molecular information

IDH1 encodes a dimeric cytosolic NADP-dependent isocitrate dehydrogenase that catalyzes decarboxylation of isocitrate into alpha-ketoglutarate (Nekrutenko et al., 1998; pubmed:9866202). [from MIM:147700; 2017.04.17] IDH2 encodes a mitochondrial version of the enzyme. [from MIM:147650; 2017.04.17]

External links
Disease synonyms
acute myeloid leukemia, IDH1,2-related
CN-AML
cytogenetically normal acute myeloid leukemia
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to one: 2 human to 1 Drosophila.

    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to one: 2 human to 1 Drosophila.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Gene Snapshot
      Isocitrate dehydrogenase (Idh) encodes a cytosolic enzyme that catalyzes the oxidative decarboxylation of isocitrate to 2-oxoglutarate, with the concomitant reduction of NADP[+] to NADPH. It functions, along with Men, G6pd, and Pgd, in a small network of NADP reducing enzymes. [Date last reviewed: 2019-03-07]
      Gene Groups / Pathways
      Comments on ortholog(s)

      High-scoring ortholog of human gene IDH1; lower-scoring ortholog of human gene IDH2 (1 Drosophila to 2 human). Dmel\Idh shares shares 72% identity and 87% similarity with the human IDH1 gene; it shares 65% identity and 80% similarity with the human IDH2 gene.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (3 groups)
        protein-protein
        Interacting group
        Assay
        References
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        Alleles Reported to Model Human Disease (Disease Ontology) (3 alleles)
        Models Based on Experimental Evidence ( 2 )
        Modifiers Based on Experimental Evidence ( 1 )
        Allele
        Disease
        Interaction
        References
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        loss of function allele
        P-element activity
        loss of function allele
        natural population
        loss of function allele
        natural population
        loss of function allele
        natural population
        amorphic allele - molecular evidence
        Delta2-3 transposase
        References (11)